Table 1 Clinicopathological characteristics of study subjects
Characteristics | Number (%) |
|---|---|
Age (years) | |
< 40 | 44 (13.3) |
40 ~ 49 | 129 (38.9) |
50 ~ 59 | 123 (37.0) |
≥ 60 | 36 (10.8) |
Menopausal status | |
Postmenopause | 127 (38.3) |
Time since diagnosis (years) | |
≤ 1 | 73 (22.0) |
> 1, ≤ 3 | 160 (48.2) |
> 3, ≤ 5 | 66 (19.9) |
> 5 | 33 (9.9) |
Family history of breast cancer | |
Yes | 27 (8.1) |
Operation method of breast | |
BCS | 225 (67.8) |
Mastectomy | 79 (23.8) |
(NA)SSM | 28 (8.4) |
Operation method of axilla | |
SLNB | 212 (63.9) |
ALND | 120 (36.1) |
TNM stage | |
0 | 13 (3.9) |
I | 129 (38.9) |
II | 148 (44.6) |
III & IV | 42 (12.6) |
Multiplicity | |
Yes | 62 (18.7) |
Estrogen receptor | |
Positive | 260 (78.3) |
Progesterone receptor | |
Positive | 240 (72.3) |
HER2 | |
Positive | 95 (28.6) |
Chemotherapy | |
Yes | 248 (74.7) |
Hormonal therapy | |
Yes | 236 (71.1) |
Radiation therapy | |
Yes | 262 (78.9) |
Target therapy | |
Yes | 72 (21.7) |
Co-morbidity | |
Yes | 79 (23.8) |
Adjuvant treatment | |
During | 141 (42.5) |
After | 144 (43.4) |
Othersa | 47 (14.1) |